REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
8.50
-0.35 (-3.95%)
At close: Feb 11, 2026, 4:00 PM EST
8.60
+0.10 (1.18%)
After-hours: Feb 11, 2026, 7:12 PM EST
REGENXBIO Market Cap
REGENXBIO has a market cap or net worth of $430.3 million as of February 11, 2026. Its market cap has increased by 13.24% in one year.
Market Cap
430.30M
Enterprise Value
396.39M
1-Year Change
13.24%
Ranking
Category
Stock Price
$8.50
Market Cap Chart
Since September 17, 2015, REGENXBIO's market cap has decreased from $749.30M to $430.30M, a decrease of -42.57%. That is a compound annual growth rate of -5.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 448.00M | -38.55% |
| Dec 31, 2025 | 729.00M | 90.34% |
| Dec 31, 2024 | 383.00M | -51.50% |
| Dec 29, 2023 | 789.70M | -19.57% |
| Dec 30, 2022 | 981.90M | -29.79% |
| Dec 31, 2021 | 1.40B | -17.57% |
| Dec 31, 2020 | 1.70B | 12.32% |
| Dec 31, 2019 | 1.51B | 0.48% |
| Dec 31, 2018 | 1.50B | 45.18% |
| Dec 29, 2017 | 1.04B | 110.87% |
| Dec 30, 2016 | 491.10M | 12.43% |
| Dec 31, 2015 | 436.80M | -41.71% |
| Sep 17, 2015 | 749.30M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DiaMedica Therapeutics | 444.17M |
| Vanda Pharmaceuticals | 439.09M |
| Lineage Cell Therapeutics | 436.19M |
| Assembly Biosciences | 432.76M |
| Kyverna Therapeutics | 431.33M |
| Eupraxia Pharmaceuticals | 428.60M |
| vTv Therapeutics | 427.61M |
| PureTech Health | 425.38M |